Bruker | BRKR - Cash And Equivalent


Bruker reported $293.1M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
ABB USD 4.64B 703M Dec/2025
Agilent USD 1.76B 31M Dec/2025
Ametek USD 457.95M 18.71M Dec/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 529.8M 134M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Danaher USD 4.62B 3.09B Dec/2025
Fujikura JPY 153.99B 12.32B Sep/2025
Furukawa JPY 15.46B 409M Sep/2025
General Electric Aerospace USD 12.39B 109M Dec/2025
Hitachi JPY 1.28T 412.69B Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
Illumina USD 1.42B 368M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
Mitsubishi Electric JPY 862.84B 105.51B Sep/2025
Mitsubishi Heavy Industries JPY 716.1B 44.22B Sep/2025
Myriad Genetics USD 149.6M 4.2M Dec/2025
Nikon Corporation JPY 164.74B 1.15B Jun/2025
Olympus JPY 147.24B 93.98B Sep/2025
Repligen USD 566.02M 182.73M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Smiths GBP 345M 47M Dec/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Waters USD 587.83M 128.71M Dec/2025